NIH gives $129M to 9 companies to boost COVID-19 testing

Check out the NIHs full news release here..

Maia Anderson –
Thursday, September 3rd, 2020
Print|Email.

The contracts are part of the NIHs Rapid Acceleration of Diagnostics, or RADx, program it began in late April to speed the development of COVID-19 tests..

The nine companies receiving the cash are:.

The National Institutes of Health stated Sept. 2 that it is offering $129.3 million to 9 companies to scale up production of COVID-19 tests..

MatMaCorp in Lincoln, Neb..
Maxim Biomedical in Rockville, Md
. MicroGEM International in Charlottesville, Va..
Aegis Sciences in Nashville, Tenn..
Broad Institute in Cambridge, Mass..
Ceres Nanoscience in Manassas, Va..
Illumina in San Diego.
PathGroup in Nashville, Tenn..
Sonic Healthcare USA in Austin, Texas.

More articles on supply chain: Amazons shipment drones cleared for takeoffUS awards Abbott $760M contract for quick COVID-19 testsMedical device recalls rise 31% in Q2.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by clicking here.

The money will support establishing innovations for COVID-19 tests, such as portable point-of-care tests that can offer instant outcomes. The new innovations will considerably increase the number, type and accessibility of tests by millions each week this fall, the NIH said..